MiNK Therapeutics INKT
NASDAQ INKT
$12.26 +0.15 (+1.24%)
At close: Sep 29, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Total Current Liabilities (2020 - 2026)

Updated

MiNK Therapeutics (INKT) posted Total Current Liabilities of $7.57 million for Q2 2026, down 42.5% from $13.16 million a year earlier but up 3.9% from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, MiNK Therapeutics' Total Current Liabilities came in at $13.03 million, up 87.2% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • In prior years, MiNK Therapeutics' Total Current Liabilities was $6.96 million in FY2024 (-39.0%), $11.4 million in FY2023 (-10.1%), $12.68 million in FY2022 (-23.0%) and $16.47 million in FY2021 (+15.8%).
  • Quarterly Total Current Liabilities has run from a low of $6.96 million in Q4 2024 to a high of $80.56 million in Q3 2021 over five years.
  • On a year-over-year basis, Total Current Liabilities increased in four of the last eight quarters, with growth averaging 7.2%.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q4 2025, with growth of 87.2%; the weakest was Q3 2022, with a decline of 77.1%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $7.29 million (Q1 2026), $13.03 million (Q4 2025) and $13.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 MiNK Therapeutics 61.82 Mn 61.82 Mn - 7.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.57 Mn
Mar 31, 2026 7.29 Mn
Dec 31, 2025 13.03 Mn
Sep 30, 2025 13.43 Mn
Jun 30, 2025 13.16 Mn
Mar 31, 2025 12.12 Mn
Dec 31, 2024 6.96 Mn
Sep 30, 2024 7.40 Mn
Jun 30, 2024 10.15 Mn
Mar 31, 2024 11.11 Mn
Dec 31, 2023 11.40 Mn
Sep 30, 2023 10.39 Mn
Jun 30, 2023 11.46 Mn
Mar 31, 2023 11.25 Mn
Dec 31, 2022 12.68 Mn
Sep 30, 2022 18.45 Mn
Jun 30, 2022 17.43 Mn
Mar 31, 2022 18.83 Mn
Dec 31, 2021 16.47 Mn
Sep 30, 2021 80.56 Mn
API Access

MiNK Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INKT&period=max&api_key=YOUR_API_KEY